PMOS: the new name for PCOS
Key Takeaways
PMOS is the new consensus name for PCOS. The rename does not change an earlier PCOS diagnosis, and “polycystic” describes many small follicles rather than true ovarian cysts. See the full guide for diagnosis and care.
Key evidence: Lancet — PMOS naming consensus (2026) 2023 International Evidence-based Guideline (Teede et al.) Monash University — PMOS guideline terminology update (2026)
What changed — and what did not
PMOS stands for polyendocrine metabolic ovarian syndrome. In 2026, a global consensus published in The Lancet chose it to replace polycystic ovary syndrome (PCOS). It is not a new illness: the new name points to the condition’s wider hormonal and metabolic features.
During a three-year transition, clinics and labs may still use PCOS or list both names as PMOS (formerly called PCOS).
The rename does not alter your diagnosis or care. Monash University notes that the 2026 terminology update left the 2023 advice and content unchanged. The international guideline will use PMOS alone from its 2028 update.
For diagnosis, treatment, fertility and IVF, see our full PCOS/PMOS guide.
Why was “PCOS” misleading?
The old name made it sound as if ovarian cysts defined the condition. On an ultrasound scan, “polycystic” simply describes ovaries with many small follicles, as explained in the 2023 guideline. These follicles are not cysts that need surgery. A true ovarian cyst, if one is found, is assessed separately; read more about functional ovarian cysts.
What should patients do during the transition?
You do not need to repeat tests or change your treatment just because the name has changed. If a report uses a term you don’t recognise, ask your clinician to explain it.
Frequently Asked Questions for Dr. Aksoy
Are PMOS and PCOS the same condition, and which term will appear on my medical report?
Yes, PMOS and PCOS refer to the same condition under different names. PCOS stands for “polycystic ovary syndrome”, the former English name (called SOPK in French). In May 2026, a new international name was proposed: PMOS (Polyendocrine Metabolic Ovarian Syndrome), translated into French as SMOP (syndrome métabolique ovarien polyendocrinien).
This change aims to better describe a condition that involves not only the ovaries, but also hormones and metabolism. Contrary to what the old name suggested, these are not true cysts, and not all affected women necessarily show a polycystic appearance on ultrasound.
Your medical report may therefore still show PCOS or SOPK, which remain widely used, while PMOS and SMOP will appear gradually. This name change does not affect your diagnosis, the diagnostic criteria or the recommended treatments. If you have already been diagnosed with PCOS, you do not have a new illness: only its name is changing.
Sources
- Teede HJ, Bahri Khomami M, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026;407(10545):2329–2339. doi:10.1016/S0140-6736(26)00717-8. PMID: 42119588.
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertil Steril. 2023;120(4):767–793. doi:10.1016/j.fertnstert.2023.07.025. PMID: 37589624.
- Monash Centre for Health Research and Implementation. International Evidence-based Guideline: May 2026 terminology update for PMOS. 2026.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.